SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028318
Filing Date
2021-11-15
Accepted
2021-11-15 07:05:34
Documents
54
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 661716
2 ex31-1.htm EX-31.1 17412
3 ex31-2.htm EX-32.2 17835
4 ex32-1.htm EX-32.1 8011
5 ex32-2.htm EX-32.2 7978
  Complete submission text file 0001493152-21-028318.txt   3578376

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ntec-20210930.xsd EX-101.SCH 46987
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ntec-20210930_cal.xml EX-101.CAL 40536
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ntec-20210930_def.xml EX-101.DEF 111958
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ntec-20210930_lab.xml EX-101.LAB 324045
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ntec-20210930_pre.xml EX-101.PRE 215611
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 442716
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40652 | Film No.: 211406253
SIC: 2834 Pharmaceutical Preparations